July Bulletin – COVID-19 CPT Code Updates

July Bulletin – COVID-19 CPT Code Updates In mid-May, the U.S. Food and Drug Administration (FDA) approved use of the Pfizer-BioNTech COVID-19 vaccine booster for children ages five through eleven. The CPT code to be used for this booster is: 0074A – Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) […]

June Bulletin – COVID-19 Vaccine Updates

COVID-19 Vaccine Updates On June 17, 2022, the Food and Drug Administration (FDA) authorized COVID-19 vaccines for children as young as 6 months old. The Centers for Disease Control and Prevention (CDC) approved the vaccine for children under five a day later, making approximately 20 million children eligible for daycare or preschool. Both the Moderna […]

February Bulletin – Stay Up-To-Date on COVID-19 Vaccine Coding

COVID-19 vaccines have been available for more than a year and with boosters being approved and recommended, it is easy to bill with an incorrect vaccine or administration code. Below are the most used COVID-19 vaccination codes: CPT/HCPCS Description CPT/HCPCS Code Vaccine/Procedure Name SARSCOV2 VAC 30MCG/0.3ML IM 91300 Pfizer-BioNTech COVID-19 Vaccine ADM SARSCOV2 30MCG/0.3ML 1ST […]

January Bulletin – COVID-19 Updates

  CMS Now Requiring Payers to Cover At-Home Testing Effective January 15, 2022, patients with a health insurance plan can go online or to a pharmacy and purchase at-home COVID-19 tests at no cost. This will happen through reimbursement or free of charges through insurance. If a patient is required to pay for a test […]

December Bulletin – COVID-19 Updates

COVID-19 Updates Omicron Variant: What to Know On November 24, a new variant of the COVID-19 virus was reported to the World Health Organization (WHO). Two days later on November 26, the WHO classified the Omicron Variant as a “Variant of Concern.” The first detected cases were found in Botswana and South Africa and have […]

October Bulletin – COVID-19 Vaccine Updates

COVID-19 Vaccine Updates Vaccines for Children In late September, Pfizer announced that the Phase 2/3 trial for children 5 to 11 showed that their COVID-19 vaccine was safe and generated a “robust” antibody response. The trial included more than 2.200 participants and used a two-dose regimen of the vaccine administered three weeks apart. This trial […]

September Bulletin – COVID-19 Updates – Part 2

COVID-19 Updates – Part 2 THE AMA ADDS CPT CODE FOR THIRD COVID-19 VACCINATION  In mid-August, the American Medical Association announced the code set for the third doses of the Pfizer and Moderna COVID-19 vaccines. Below are the codes for both the Pfizer-BioTech & the Moderna vaccines: 91300: this is for the Pfizer vaccine only. For […]

September Bulletin – COVID-19 Updates – Part 1

COVID-19 Updates – Part 1   USFDA APPROVES FIRST COVID-19 VACCINE On August 23 the U.S. Federal Drug Administration approved Pfizer-BioNTech’s COVID-19 Vaccine. It will now referred to as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine will be available for emergency use for individuals […]


The COVID-19 Delta Variant The SARS-CoV-2  B.1.617.2 (Delta) variant was discovered in India in late 2020 and it has since become the dominant strain in the United States. The Delta Variant is More Contagious The World Health Organization (WHO) has called the Delta Variant the “fastest and fittest” strain. The Centers for Disease Control and […]